Sana Biotechnology Inc vs Tapestry, Inc. — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Tapestry, Inc. trades at $140.62 (market cap $28.51B). The key difference: Tapestry, Inc. is far larger — about 32.6× Sana Biotechnology Inc's market cap, and Tapestry, Inc. pays a 1.13% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | TPR | |
|---|---|---|
Market Cap | $873.84M | $28.51B |
Sector | Health | Consumer Cyclical |
52-Week High | $5.92 | $160.49 |
52-Week Low | $2.68 | $95.69 |
Enterprise Value | $848.03M | $31.37B |
Dividend Yield | — | 1.13% |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Coach, Kate Spade, and Stuart Weitzman are the fashion and accessory brands that comprise Tapestry. The firm's products are sold through about 1,400 company-operated stores, wholesale channels, and e-commerce in North America (67% of fiscal 2022 sales), Europe, Asia (28% of fiscal 2022 sales), and elsewhere. Coach (74% of fiscal 2022 sales) is best known for affordable luxury leather products. Kate Spade (22% of fiscal 2022 sales) is known for colorful patterns and graphics. Women's handbags and accessories produced 69% of Tapestry's sales in fiscal 2022. Stuart Weitzman, Tapestry's smallest brand, generates nearly all its revenue from women's footwear.
Read more on TPR →